Home Clinical Topics FDA approves drug for rare lung disease

FDA approves drug for rare lung disease

On May 28, the U.S. Food and Drug Administration (FDA) approved Rapamune (sirolimus), to treat lymphangioleiomyomatosis, a rare, progressive lung disease that primarily affects women of childbearing age. This is the first drug approved to treat the disease. Read more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here